# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA630098 | P | Partition coefficient (logP) | 28 | ALA1136781 | small-molecule physicochemical format | Scientific Literature | ||
2. | ALA633323 | P | Partition coefficient (logP) | 2 | ALA1133572 | small-molecule physicochemical format | Scientific Literature | ||
3. | ALA642697 | A | Oral bioavailability in dog | Canis lupus familiaris | 2 | ALA1133572 | organism-based format | Scientific Literature | |
4. | ALA642699 | A | oral bioavailability in monkeys | Simiiformes | 1 | ALA1133572 | organism-based format | Scientific Literature | |
5. | ALA642700 | A | Oral bioavailability in rat | Rattus norvegicus | 2 | ALA1133572 | organism-based format | Scientific Literature | |
6. | ALA664809 | A | Inhibition of human cytochrome P450 3A4 | 28 | ALA1136781 | single protein format | Scientific Literature | ||
7. | ALA688599 | F | Compound was evaluated for Antiviral activity against HIV-1 | Human immunodeficiency virus 1 | 3 | ALA1134626 | organism-based format | Scientific Literature | |
8. | ALA696065 | B | Compound was tested for inhibitory activity against HIV-1 protease | 8 | ALA1135947 | single protein format | Scientific Literature | ||
9. | ALA710714 | F | Anti-HIV-1 activity against mutant HIV-1 in MT-4 cells (mutation selected with compound 1) | Human immunodeficiency virus 1 | 23 | ALA1134445 | cell-based format | Scientific Literature | |
10. | ALA710715 | F | Anti-HIV-1 activity against mutant HIV-1 in MT-4 cells (mutation selected with nelfinavir) | Human immunodeficiency virus 1 | 23 | ALA1134445 | cell-based format | Scientific Literature | |
11. | ALA879740 | F | Anti-HIV-1 activity against mutant HIV-1 in MT-4 cells (mutation selected with ritonavir) | Human immunodeficiency virus 1 | 23 | ALA1134445 | cell-based format | Scientific Literature | |
12. | ALA710716 | F | Anti-HIV-1 activity against mutant HIV-1 in MT-4 cells (mutation selected with saquinavir) | Human immunodeficiency virus 1 | 22 | ALA1134445 | cell-based format | Scientific Literature | |
13. | ALA715133 | F | Anti-HIV-1 activity against Wild type virus in MT-4 cells | Human immunodeficiency virus 1 | 22 | ALA1134445 | cell-based format | Scientific Literature | |
14. | ALA706835 | F | Antiviral activity against PI resistant virus D545701 was determined in MT-4 cell line | Homo sapiens | 11 | ALA1138692 | cell-based format | Scientific Literature | |
15. | ALA706836 | F | Antiviral activity against PI resistant virus EP13 was determined in MT-4 cell line | Homo sapiens | 11 | ALA1138692 | cell-based format | Scientific Literature | |
16. | ALA706838 | F | Antiviral activity against wild-type HIV virus (HXB2) was determined in MT-4 cell line | Homo sapiens | 11 | ALA1138692 | cell-based format | Scientific Literature | |
17. | ALA712255 | F | Compound was evaluated for its antiviral inhibition in MT-4 cell culture | Homo sapiens | 11 | ALA1133027 | cell-based format | Scientific Literature | |
18. | ALA755826 | F | Inhibition of P-glycoprotein using ATPase in MDR1 membranes | 28 | ALA1136781 | cell membrane format | Scientific Literature | ||
19. | ALA755827 | F | Inhibition of P-glycoprotein, human L-MDR1 expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay | 28 | ALA1136781 | cell-based format | Scientific Literature | ||
20. | ALA755828 | F | Inhibition of P-glycoprotein, mouse L-mdr1a expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay | 28 | ALA1136781 | cell-based format | Scientific Literature |